Dr. Annamaria Sangiorgi, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
Dr. Scott Thomas Terwilliger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-3241 Fax: 570-887-3236 |
Jessica Bulkley, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
Dr. Jordan T Cook, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-3241 Fax: 570-887-3236 |
Dr. Michael John Benyo, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-3236 |
Haley Catherine Sorber, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 800-474-4482 |
Dr. Tracy L Fish, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
Dr. James M. Gabriel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
Dr. Frank Louis Galizia, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
Guthrhie Medical Group, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |
News Archive
The Federation of State Medical Boards has approved a report that lays the groundwork for strengthening the medical licensure renewal process by implementing new standards for lifelong learning among physicians.
Agilent Technologies Inc. has completed the acquisition of specific assets of A2 Technologies. Financial details were not disclosed for the acquisition, which was first announced Jan. 19.
Health care management is growing in popularity among business schools, according to a report in the New York Times. "Health care is the target career for 10 percent of students working on a master of business administration degree at Harvard Business School," according to the Times. Many other universities are also highlighting programs that meld health care and management.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
In a new study by researchers in the UK, Germany and South Africa, this process is visualized using time-lapse microscopy of a human cell lung line, demonstrating that SARS-CoV-2 can induce cell-to-cell fusion within 6 hours post-infection. Further, the application of neutralizing monoclonal antibodies or convalescent plasma was unable to prevent the spread of the virus by this mechanism, suggesting that removing SARS-CoV-2 from cells permissive of cell membrane fusion could be more difficult than other types of cell.
› Verified 6 days ago